TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
16.52
+0.08 (+0.49%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close16.44
Open16.25
Bid0.00 x 0
Ask0.00 x 0
Day's Range16.17 - 16.72
52 Week Range10.85 - 38.31
Volume24,607,871
Avg. Volume24,584,245
Market Cap16.784B
Beta0.63
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.34 (2.12%)
Ex-Dividend Date2017-11-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • 2018 is setting up like 2006—a boom year 2 years before the financial crisis
    Yahoo Finance Video2 days ago

    2018 is setting up like 2006—a boom year 2 years before the financial crisis

    Yahoo Finance's Alexis Christoforous and Jared Blikre discuss the current market action.

  • Teva Pharma continues to lead the IQ100
    CNBC Videosyesterday

    Teva Pharma continues to lead the IQ100

    The CNBC IQ100 index beating the broader market over one year up over 19%. Today's leaders include Teva Pharma, Cardinal Health and Mattel. The laggards Sony, Kimberly-Clark and Clorox.

  • Why Shares of Teva Are on the Rise
    Bloomberg Video4 days ago

    Why Shares of Teva Are on the Rise

    Dec.08 -- Teva Pharmaceutical Industries Ltd. is considering cutting as many as 10,000 jobs as new CEO Kare Schultz seeks to pare costs, according to people with knowledge of the matter. Bloomberg's Abigail Doolittle reports on "Bloomberg Markets."

  • Teva Pharma among IQ100 leaders
    CNBC Videos4 days ago

    Teva Pharma among IQ100 leaders

    The CNBC iq100, up over 19%. Today's leaders include Teva Pharma, Micron, and Western Digital. The laggards, General Mills, Mattel and Johnson Controls.

  • Reuters13 hours ago

    Teva's Yitzhak Peterburg resigns from board

    Teva Pharmaceuticals Industries Ltd said on Tuesday Yitzhak Peterburg, who previously served as the company's chairman and interim chief executive, resigned from its board, effective immediately. The debt-laden ...

  • Market Realist18 hours ago

    Spectrum Pharmaceuticals’ Product Licensing Agreements

    In 2012, Spectrum Pharmaceuticals (SPPI) acquired the rights to market Zevalin outside the US from Bayer for 19 million euros.

  • Teva’s Working With Evercore to Review Debt Options
    Bloomberg19 hours ago

    Teva’s Working With Evercore to Review Debt Options

    Teva Pharmaceutical Industries Ltd.’s new Chief Executive Officer Kare Schultz is working with advisory firm Evercore Inc. to review options for the beleaguered drugmaker’s outstanding debt, according ...

  • TheStreet.comyesterday

    Teva Stock Rises After Announcing Launch of Generic Viagra Competitor

    Viagra has annual sales of about $1.4 billion.

  • Sex, Drugs, and Teva Pharmaceutical Industries (TEVA)
    SmarterAnalyst2 days ago

    Sex, Drugs, and Teva Pharmaceutical Industries (TEVA)

    Today, the generic drug giant announced the exclusive launch of its generic Viagra (sildenafil citrate) tablets in the U.S. Viagra (generic name sildenafil) is a drug used in the treatment of erectile dysfunction, also known as impotence. Introduced by Pfizer Inc. in March 1998, Viagra has generated about $1.4 billion in the U.S., according to IMS data as of August 2017.

  • Monday’s Vital Data: Facebook Inc (FB), Monsanto Company (MON) and Teva Pharmaceutical Industries Limited (TEVA)
    InvestorPlace2 days ago

    Monday’s Vital Data: Facebook Inc (FB), Monsanto Company (MON) and Teva Pharmaceutical Industries Limited (TEVA)

    U.S. stock futures are trading broadly higher this morning, putting the major market indices on track for fresh all-time highs. Wall Street is showing little fear ahead of Wednesday’s Federal Reserve meeting, when the central bank is expected to hike interest rates for the third and final time of 2017.  Furthermore, the European Central Bank and the Bank of England are also scheduled to make policy announcements this week. Heading into the open, Dow Jones Industrial Average futures have gained 0.16%, S&P 500 futures have added 0.06% and Nasdaq-100 futures have rallied 0.09%.

  • MarketWatch2 days ago

    Teva's stock gains after exclusive launch of generic Viagra

    Shares of Teva Pharmaceutical Industries Ltd. rose 0.4% in morning trade Monday, after the drug maker announced the exclusive launch of its generic Viagra tablets in the U.S. The company said it will offer ...

  • Why Chicago Bridge & Iron, Teva Pharmaceutical Industries, and Sage Therapeutics Jumped Today
    Motley Fool4 days ago

    Why Chicago Bridge & Iron, Teva Pharmaceutical Industries, and Sage Therapeutics Jumped Today

    Find out how these stocks led the market higher.

  • Reuters5 days ago

    Teva considering cutting up to 10,000 jobs: Bloomberg

    No final decision has been taken, and the targets may be modified, with a range of 5,000 to 10,000 jobs being discussed, Bloomberg reported. "We don't comment on market rumors," Teva spokeswoman Denise Bradley said in an emailed statement. Teva is saddled with nearly $35 billion in debt after its $40.5 billion acquisition of Allergan Plc's (AGN.N) generic drug business last year.

  • Teva Pharmaceutical Stock Surges on Job Cuts Talk
    InvestorPlace5 days ago

    Teva Pharmaceutical Stock Surges on Job Cuts Talk

    A recent report claims that Teva Pharmaceutical Industries Ltd (ADR) is possibly looking to cut as many as 10,000 jobs. Teva Pharmaceutical Industries Ltd (ADR) has massive amounts of debt that it needs to deal with and cutting costs with the job cuts could be good news for TEVA stock. The talk of job cuts at Teva Pharmaceutical Industries Ltd (ADR) come with additional cost savings efforts the company may be working toward.